-
2m 12sPart 1 | Session 2 2 Trials That Will Change My Practice with Prof Rasha Al-Lamee
-
3m 51sPart 1 | Session 3 3 Ways AI Will Change Your Practice
-
21m 50sPart 1 | Session 4 TCT 25 Structural Interventions Highlights
-
5m 33sPart 2 | Session 1 SELUTION DeNovo: 1-Year Results Comparing Sirolimus Balloon vs DES in PCI
-
5m 49s
-
20m 17sPart 2 | Session 4 TRILUMINATE Pivotal Trial: Lessons Learned from Tricuspid TEER
-
10m 9sPart 2 | Session 5 Real-World EVOQUE Outcomes from TVT Registry
-
8m 6sPart 2 | Session 6 PASCAL Precision System in Complex Degenerative MR
-
7m 2sPart 2 | Session 7 PREVUE-VALVE: Prevalence of Valvular Heart Disease in Older Americans
-
7m 4s
-
6m 55sPart 2 | Session 9 Short-CUT: Lithotripsy Vs Cutting Balloon for CAD
-
4m 10sPart 2 | Session 10 10-Year Mortality in NOBLE: PCI vs CABG for Left Main Disease
-
28m 2sPart 2 | Session 11 1-Year ENCIRCLE TMVR Results with SAPIEN M3
-
10m 32s
-
14m 58s
TCT 2025 - Dr Mirvat Alasnag (King Fahad Armed Forces Hospital, SA) reviews the most impactful late-breaking trials in structural cardiology, coronary interventions, and AI from TCT 2025.
Key trials:
0:40 – SUMMIT MAC (Tendyne TMVR in MAC)
2:25 – PARTNER 3 (7-year TAVR outcomes)
4:10 – CONFIRM 2 AI & angiography-derived physiology
6:05 – SHORTCUT (IVL vs cutting balloon)
7:45 – VICTORY (OPN vs IVL)
Editor: Mirjam Boros, Jordan Rance
Videogrphers: Tom Green, Dan Brent
Support: This is an independent interview produced by Radcliffe Cardiology.
Stay Updated with Our TCT 2025 Video Coverage
We’re bringing you independent, critical insights straight from TCT 2025.
Join Prof Nicolas Van Mieghem in Cardiology Conference Perspectives as he discusses what the late-breaking data could mean for your practice.
Don’t miss our short Expert Interviews with investigators, offering concise analyses and practical take-home messages.
Hear Dr Mirvat Alasnag and Dr Rasha Al-Lamee share their views on the data they believe will have the greatest impact on clinical practice.
Follow the hot topics driving innovation in interventional cardiology, and stay tuned for fresh perspectives, real-world insights and global viewpoints, all coming soon on Transcatheter Academy.
More from this programme
Part 1
Highlights
Part 2
Expert Interviews
Part 3
NVM Cardiology Conference Perspectives
A focused video series where Prof Nicolas Van Mieghem offers expert reflections on the most impactful late-breaking trials shaping interventional cardiology at TCT 2025.
Faculty Biographies
Mirvat Alasnag
Director of Catheterization Laboratory
Dr Mirvat Alasnag is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3), joining the board in October 2020 and is also on the editorial board for US Cardiology Review (USC).
Dr Mirvat Alasnag is the Director of the Catheterization Laboratory at the King Fahad Armed Forces Hospital in Jeddah, Saudi Arabia. She was the first female interventional cardiologist in the Gulf region and has since represented women on multiple medical committees, including the Saudi Arabian Cardiac Interventional Society Board & the EAPCI Women’s Steering Committee. She is the current ACCWIC International Working Group Chair and an SCAI WIN member.
Dr Alasnag trained in Clinical Cardiology and Interventional Cardiology at Loma Linda University Medical Center (Loma Linda, California) and Harper University Hospital, Detroit Medical Center (Detroit, Michigan), respectively. Since her graduation in 2009 to date, she has been…
Comments